Dudediligence.

Eloxx Pharmaceuticals, Inc

ELOXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$6.3MDec ’22−$6.2MMar ’23−$4.3MJun ’23−$3.6MSep ’23−$2.9MDec ’23−$1.7MMar ’25−$3.8MMar ’26−$4.5MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Revenuenone on file$0.00$6.4M$0.00none on file
Operating income−$34.4M−$17.3M−$2.5M−$6.4Mnone on file
Net income−$36.1M−$17.1M−$3.1M−$6.0Mnone on file
Operating cash flow−$31.8M−$14.3M−$4.7M−$6.3Mnone on file
Free cash flow−$31.9Mnone on filenone on filenone on filenone on file
Cash$19.2M$1.1M$111,000$4.8M$62.0M
Debt$12.5M$3.8M$6.5M$1.0M$0.00
Shares outstanding2.2M3.1M3.5M4.8M4.0M